Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Colgate-Palmolive

This article was originally published in The Tan Sheet

Executive Summary

Javier Teruel to chief growth officer, a newly created position overseeing global business development, R&D, information technology and strategic planning. Teruel's promotion is part of a plan to help Colgate build momentum and global growth. He previously was Colgate Europe president and general manager of Mexico. In addition, Lois Juliber is tapped as chief operating officer, responsible for operations in Europe, Latin America, Asia and Africa. Prior to her promotion, Juliber oversaw the North American and European businesses as operations chief for developed markets. North America President Ian Cook and Latin America President Michael Tangney add exec VP titles to their existing positions

Javier Teruel to chief growth officer, a newly created position overseeing global business development, R&D, information technology and strategic planning. Teruel's promotion is part of a plan to help Colgate build momentum and global growth. He previously was Colgate Europe president and general manager of Mexico. In addition, Lois Juliber is tapped as chief operating officer, responsible for operations in Europe, Latin America, Asia and Africa. Prior to her promotion, Juliber oversaw the North American and European businesses as operations chief for developed markets. North America President Ian Cook and Latin America President Michael Tangney add exec VP titles to their existing positions.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS091031

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel